Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions
- 25 August 2003
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1642 (3) , 129-138
- https://doi.org/10.1016/s0167-4889(03)00120-4
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated LysosphingolipidsJournal of Biological Chemistry, 2001
- Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic ProteoglycansArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Role of Group II Secretory Phospholipase A2in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Molecular Cloning of the Human ATP-Binding Cassette Transporter 1 (hABC1): Evidence for Sterol-Dependent Regulation in MacrophagesBiochemical and Biophysical Research Communications, 1999
- Expression of Phospholipase A 2 Isoforms in Human Normal and Atherosclerotic Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Potent Inhibitors of Secretory Phospholipase A2: Synthesis and Inhibitory Activities of Indolizine and Indene DerivativesJournal of Medicinal Chemistry, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Behaviour of phospholipase-modified HDL towards cultured hepatocytes. I. Enhanced transfers of HDL sterols and apoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983